11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid has been researched along with cannabigerol in 3 studies
| Studies (11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid) | Trials (11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid) | Recent Studies (post-2010) (11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid) | Studies (cannabigerol) | Trials (cannabigerol) | Recent Studies (post-2010) (cannabigerol) |
|---|---|---|---|---|---|
| 304 | 27 | 103 | 103 | 3 | 89 |
| Protein | Taxonomy | 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid (IC50) | cannabigerol (IC50) |
|---|---|---|---|
| Inhibin alpha chain | Homo sapiens (human) | 5.2 | |
| Cannabinoid receptor 1 | Homo sapiens (human) | 3.31 | |
| Cannabinoid receptor 2 | Homo sapiens (human) | 3.46 | |
| Transient receptor potential cation channel subfamily M member 8 | Homo sapiens (human) | 0.16 | |
| Transient receptor potential cation channel subfamily V member 1 | Homo sapiens (human) | 2.6 | |
| Transient receptor potential cation channel subfamily M member 8 | Rattus norvegicus (Norway rat) | 0.16 | |
| Transient receptor potential cation channel subfamily V member 4 | Homo sapiens (human) | 1.3 | |
| Transient receptor potential cation channel subfamily V member 2 | Rattus norvegicus (Norway rat) | 1.5 | |
| Transient receptor potential cation channel subfamily V member 2 | Homo sapiens (human) | 1.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Desrosiers, NA; Huestis, MA; Scheidweiler, KB | 1 |
| Barnes, AJ; Huestis, MA; Newmeyer, MN; Scheidweiler, KB | 1 |
| Andersson, M; Huestis, MA; Scheidweiler, KB; Sempio, C; Swortwood, MJ | 1 |
3 other study(ies) available for 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid and cannabigerol
| Article | Year |
|---|---|
Quantification of six cannabinoids and metabolites in oral fluid by liquid chromatography-tandem mass spectrometry.
Topics: Cannabidiol; Cannabinoids; Chromatography, Liquid; Dronabinol; Humans; Limit of Detection; Saliva; Solid Phase Extraction; Tandem Mass Spectrometry | 2015 |
Quantification of cannabinoids and their free and glucuronide metabolites in whole blood by disposable pipette extraction and liquid chromatography-tandem mass spectrometry.
Topics: Biomarkers; Cannabidiol; Cannabinoids; Chromatography, Liquid; Dronabinol; Glucuronides; Humans; Marijuana Smoking; Substance Abuse Detection; Tandem Mass Spectrometry | 2016 |
Long-term stability of cannabinoids in oral fluid after controlled cannabis administration.
Topics: Adolescent; Adult; Cannabidiol; Cannabinoids; Cannabis; Chromatography, Liquid; Dronabinol; Drug Stability; Female; Humans; Male; Marijuana Smoking; Mass Spectrometry; Middle Aged; Saliva; Substance Abuse Detection; Young Adult | 2017 |